ATE179610T1 - Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten - Google Patents

Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten

Info

Publication number
ATE179610T1
ATE179610T1 AT95910179T AT95910179T ATE179610T1 AT E179610 T1 ATE179610 T1 AT E179610T1 AT 95910179 T AT95910179 T AT 95910179T AT 95910179 T AT95910179 T AT 95910179T AT E179610 T1 ATE179610 T1 AT E179610T1
Authority
AT
Austria
Prior art keywords
treatment
composition
dependent diseases
ovarian estrogen
estrogen
Prior art date
Application number
AT95910179T
Other languages
English (en)
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Application granted granted Critical
Publication of ATE179610T1 publication Critical patent/ATE179610T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
AT95910179T 1994-02-04 1995-02-02 Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten ATE179610T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions

Publications (1)

Publication Number Publication Date
ATE179610T1 true ATE179610T1 (de) 1999-05-15

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910179T ATE179610T1 (de) 1994-02-04 1995-02-02 Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten

Country Status (29)

Country Link
US (1) US5681817A (de)
EP (1) EP0785792B1 (de)
JP (1) JP3130048B2 (de)
KR (1) KR970700507A (de)
CN (1) CN1144486A (de)
AP (1) AP724A (de)
AT (1) ATE179610T1 (de)
AU (1) AU689229B2 (de)
BG (1) BG62238B1 (de)
BR (1) BR9506606A (de)
CA (1) CA2182183C (de)
CZ (1) CZ291709B6 (de)
DE (1) DE69509544T2 (de)
DK (1) DK0785792T3 (de)
ES (1) ES2132645T3 (de)
FI (1) FI963036A0 (de)
GR (1) GR3030164T3 (de)
HU (1) HUT74622A (de)
LT (1) LT4182B (de)
LV (1) LV11782B (de)
MD (1) MD1432C2 (de)
NZ (1) NZ281441A (de)
OA (1) OA10777A (de)
PL (1) PL178273B1 (de)
RO (1) RO117420B1 (de)
RU (1) RU2110274C1 (de)
SK (1) SK96296A3 (de)
TJ (1) TJ242B (de)
WO (1) WO1995020972A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2145286T3 (es) * 1994-07-22 2000-07-01 Hampton Roads Medical College Uso de un antagonista gnrh para la preparacion de una composicion farmaceutica.
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
EP1029868A4 (de) 1997-10-17 2003-10-22 Mochida Pharm Co Ltd Mittel gegen hysteromyomas das dienogest als wirkstoff enthält
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
WO2001015679A2 (en) * 1999-08-31 2001-03-08 Jenapharm Gmbh & Co. Kg Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
WO2002036144A1 (en) * 2000-10-30 2002-05-10 University Of Zurich Gnrh analogues for treatment of urinary incontinence
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
AU2006215300C9 (en) * 2005-02-17 2010-05-06 Hadasit Medical Research Services And Development Ltd. Bisphosphonates for treating endometriosis
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
CA2673128C (en) * 2006-10-24 2018-07-03 Repros Therapeutics Inc. Compositions and methods for suppressing endometrial proliferation
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療***依賴性病症之藥物的用途
WO2008144143A1 (en) * 2007-05-14 2008-11-27 Drugtech Corporation Endometriosis treatment
AU2008300199B2 (en) * 2007-09-20 2013-09-12 Lapidot Medical Import And Marketing Ltd Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
KR101585221B1 (ko) 2014-02-27 2016-01-13 권희완 지압대 겸용 지압 베개
EP3560555A1 (de) * 2018-04-26 2019-10-30 LifeArc Zusammensetzung zur behandlung einer oder mehrerer östrogenvermittelter krankheiten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
EP0472725B1 (de) 1990-03-16 1997-05-21 Applied Research Systems Ars Holding N.V. Behandlung polyzystischer ovarkrankheit
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
DE69509544T2 (de) 1999-09-02
AP724A (en) 1999-01-18
BR9506606A (pt) 1997-09-09
EP0785792A4 (de) 1997-07-30
LT4182B (en) 1997-06-25
LT96133A (en) 1997-01-27
CA2182183A1 (en) 1995-08-10
MD1432B2 (en) 2000-03-31
DK0785792T3 (da) 1999-10-18
RO117420B1 (ro) 2002-03-29
AP9600840A0 (en) 1996-07-31
AU689229B2 (en) 1998-03-26
TJ242B (en) 1999-11-24
CN1144486A (zh) 1997-03-05
CZ210396A3 (en) 1997-05-14
CA2182183C (en) 2003-09-16
HUT74622A (en) 1997-01-28
BG100766A (en) 1997-06-30
MD1432C2 (ro) 2000-09-30
ES2132645T3 (es) 1999-08-16
AU1838695A (en) 1995-08-21
EP0785792A1 (de) 1997-07-30
JPH09508418A (ja) 1997-08-26
HU9601969D0 (en) 1996-09-30
BG62238B1 (bg) 1999-06-30
JP3130048B2 (ja) 2001-01-31
FI963036A (fi) 1996-08-01
LV11782A (lv) 1997-06-20
DE69509544D1 (de) 1999-06-10
CZ291709B6 (cs) 2003-05-14
GR3030164T3 (en) 1999-08-31
FI963036A0 (fi) 1996-08-01
US5681817A (en) 1997-10-28
PL315792A1 (en) 1996-12-09
NZ281441A (en) 1999-09-29
EP0785792B1 (de) 1999-05-06
PL178273B1 (pl) 2000-03-31
OA10777A (en) 2002-12-23
LV11782B (en) 1997-12-20
RU2110274C1 (ru) 1998-05-10
KR970700507A (ko) 1997-02-12
SK96296A3 (en) 1997-07-09
WO1995020972A1 (en) 1995-08-10

Similar Documents

Publication Publication Date Title
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE259812T1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69526684D1 (de) Begasungsrührwerk zur Behandlung von Metallschmelzen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69905214T2 (de) Mittel zur Behandlung der Osteoporose
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee